BLUE SAIL MEDICAL: The shareholding ratio of Blue Sail Group has decreased to 10.96%
Blue Sail Medical announced that the information disclosure obligor, Blue Sail Group, has been diluted from 98% to 47.0013% in its equity stake in Blue Sail Investment due to an increase in capital from Shandong Langhui to Blue Sail Investment. As a result, the indirect controlling shareholder of Blue Sail Medical has changed from Blue Sail Group to Shandong Langhui. The shareholding ratio of Blue Sail Group in Blue Sail Medical has decreased from 23.31% to 10.96%. This equity change does not involve the buying or selling of shares, and Blue Sail Group has no plans to increase or decrease its holdings in the next 12 months
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments